Insider Makes Significant Stock buy in Amicus Therapeutics (FOLD) Shares Breaks neutral Trend of Last 90 Days

Monday, March 05, 2018 10:15 PM ET

Insider Makes Significant Stock buy in Amicus Therapeutics (FOLD) Shares Breaks neutral Trend of Last 90 Days

One Amicus Therapeutics insider — Perceptive Advisors Llc, 10% Owner — today, acquired 100,000 shares having a market value of approximately $1,369,000, as revealed in a form 4 document filed with the SEC. This is the first insider buy/sell trade in the past 90 days.

The number of buy-sell trades for Amicus Therapeutics is close to that of the 121 member peer company average. The Pharmaceuticals peer group saw 67 buy/sell trades during this period for an average of 0.6 transactions per company. However, the number of shares per buy/sell trade transacted by Amicus Therapeutics insiders is higher. Within the peer group there were 2,129,599 shares purchased and 3,942,668 shares sold with company insiders selling 27,061 shares on average.

Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data sourced in evaluating and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.